Mark Iwicki
Directeur Général chez KALA BIO, INC.
Fortune : 5 M $ au 30/04/2024
Profil
M. Mark T. Iwicki est président du conseil d'administration de Q32 Bio, Inc, président du conseil d'administration d'Akero Therapeutics, Inc, administrateur indépendant de Pulmatrix, Inc, administrateur non exécutif indépendant de Merus NV, président du conseil d'administration, président et directeur général de Kala Pharmaceuticals, Inc et administrateur indépendant d'Aimmune Therapeutics, Inc. Il est membre du conseil d'administration de Pulmatrix, Inc, Merus NV, Nimbus Therapeutics LLC, Aimmune Therapeutics, Inc, Nimbus Apollo, Inc, Oxeia Biopharmaceuticals, Inc et Pulmatrix Operating Co. M. Iwicki a été précédemment employé en tant que président, directeur général et directeur de Civitas Therapeutics, Inc. et président, directeur général et directeur de Blend Therapeutics, Inc. et président et directeur général de Sepracor Pharmaceuticals Inc. et vice-président de Novartis Pharmaceuticals Corp, vice-président et chef de l'unité commerciale cardiovasculaire chez Novartis Pharmaceuticals UK Ltd, directeur chez Astra Merck, Inc, directeur chez Merck & Co, Inc, et président et directeur général chez Sumitomo Dainippon Pharma Co, Ltd. Il a également siégé au conseil d'administration de TARIS BioMedical LLC et de la Wellesley Youth Hockey Association. Il a obtenu son diplôme de premier cycle à la Ball State University (Indiana) et un MBA à la Loyola University Maryland, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MERUS N.V.
0,13% | 07/05/2024 | 73 576 ( 0,13% ) | 3 M $ | 30/04/2024 |
THIRD HARMONIC BIO, INC.
0,32% | 31/03/2024 | 128 630 ( 0,32% ) | 1 M $ | 30/04/2024 |
KALA BIO, INC.
0,48% | 01/04/2024 | 13 625 ( 0,48% ) | 84 203 $ | 30/04/2024 |
AKERO THERAPEUTICS, INC.
-.--% | 02/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
| 12/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 | |
-.--% | 25/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Mark Iwicki
| Sociétés | Poste | Début |
|---|---|---|
| KALA BIO, INC. | Directeur Général | 01/03/2015 |
| MERUS N.V. | Directeur/Membre du Conseil | 01/07/2018 |
| AKERO THERAPEUTICS, INC. | Président | 01/04/2019 |
| AEROVATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/03/2024 |
| THIRD HARMONIC BIO, INC. | Président | 01/05/2020 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Président | 22/12/2020 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Mark Iwicki
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mark Iwicki
| Ball State University (Indiana) | Undergraduate Degree |
| Loyola University Maryland, Inc. | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| KALA BIO, INC. | Health Technology |
| MERUS N.V. | Health Technology |
| PULMATRIX, INC. | Health Technology |
| AKERO THERAPEUTICS, INC. | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
| THIRD HARMONIC BIO, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Health Technology |
Wellesley Youth Hockey Association
 Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Wellesley Youth Hockey Association is a sports organization that promotes ice hockey and values such as sportsmanship, teamwork, and respect for the rules of play. The association is based in Wellesley, Massachusetts. The association offers various programs for different age groups, including travel teams, mite programs, and goalie training. It also provides resources for coaches, officials, and parents. | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |